Global Antibody-drug Conjugate Market Research Report 2020


The global Antibody-drug Conjugate market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026.
This report focuses on Antibody-drug Conjugate volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Antibody-drug Conjugate market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Antibody-drug Conjugate market is segmented into
    Adcetris
    Kadcyla

Segment by Application
    Breast Cancer
    Lymphoma

 Global Antibody-drug Conjugate Market: Regional Analysis
The Antibody-drug Conjugate market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Antibody-drug Conjugate market report are:
North America
    U.S.
    Canada
Europe
    Germany
    France
    U.K.
    Italy
    Russia
Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
Latin America
    Mexico
    Brazil
    Argentina
Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E
Global Antibody-drug Conjugate Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Antibody-drug Conjugate market include:
    Agensys
    Concortis Biotherapeutics
    Sanofi
    Celldex Therapeutics
    Synthon Holding BV
Table of Contents

1 Antibody-drug Conjugate Market Overview
    1.1 Product Overview and Scope of Antibody-drug Conjugate
    1.2 Antibody-drug Conjugate Segment by Type
        1.2.1 Global Antibody-drug Conjugate Sales Growth Rate Comparison by Type (2021-2026)
        1.2.2 Adcetris
        1.2.3 Kadcyla
    1.3 Antibody-drug Conjugate Segment by Application
        1.3.1 Antibody-drug Conjugate Sales Comparison by Application: 2020 VS 2026
        1.3.2 Breast Cancer
        1.3.3 Lymphoma
    1.4 Global Antibody-drug Conjugate Market Size Estimates and Forecasts
        1.4.1 Global Antibody-drug Conjugate Revenue 2015-2026
        1.4.2 Global Antibody-drug Conjugate Sales 2015-2026
        1.4.3 Antibody-drug Conjugate Market Size by Region: 2020 Versus 2026

2 Global Antibody-drug Conjugate Market Competition by Manufacturers
    2.1 Global Antibody-drug Conjugate Sales Market Share by Manufacturers (2015-2020)
    2.2 Global Antibody-drug Conjugate Revenue Share by Manufacturers (2015-2020)
    2.3 Global Antibody-drug Conjugate Average Price by Manufacturers (2015-2020)
    2.4 Manufacturers Antibody-drug Conjugate Manufacturing Sites, Area Served, Product Type
    2.5 Antibody-drug Conjugate Market Competitive Situation and Trends
        2.5.1 Antibody-drug Conjugate Market Concentration Rate
        2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
        2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    2.7 Primary Interviews with Key Antibody-drug Conjugate Players (Opinion Leaders)

3 Antibody-drug Conjugate Retrospective Market Scenario by Region
    3.1 Global Antibody-drug Conjugate Retrospective Market Scenario in Sales by Region: 2015-2020
    3.2 Global Antibody-drug Conjugate Retrospective Market Scenario in Revenue by Region: 2015-2020
    3.3 North America Antibody-drug Conjugate Market Facts & Figures by Country
        3.3.1 North America Antibody-drug Conjugate Sales by Country
        3.3.2 North America Antibody-drug Conjugate Sales by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Antibody-drug Conjugate Market Facts & Figures by Country
        3.4.1 Europe Antibody-drug Conjugate Sales by Country
        3.4.2 Europe Antibody-drug Conjugate Sales by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Antibody-drug Conjugate Market Facts & Figures by Region
        3.5.1 Asia Pacific Antibody-drug Conjugate Sales by Region
        3.5.2 Asia Pacific Antibody-drug Conjugate Sales by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Antibody-drug Conjugate Market Facts & Figures by Country
        3.6.1 Latin America Antibody-drug Conjugate Sales by Country
        3.6.2 Latin America Antibody-drug Conjugate Sales by Country
        3.6.3 Mexico
        3.6.3 Brazil
        3.6.3 Argentina
    3.7 Middle East and Africa Antibody-drug Conjugate Market Facts & Figures by Country
        3.7.1 Middle East and Africa Antibody-drug Conjugate Sales by Country
        3.7.2 Middle East and Africa Antibody-drug Conjugate Sales by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Antibody-drug Conjugate Historic Market Analysis by Type
    4.1 Global Antibody-drug Conjugate Sales Market Share by Type (2015-2020)
    4.2 Global Antibody-drug Conjugate Revenue Market Share by Type (2015-2020)
    4.3 Global Antibody-drug Conjugate Price Market Share by Type (2015-2020)
    4.4 Global Antibody-drug Conjugate Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Antibody-drug Conjugate Historic Market Analysis by Application
    5.1 Global Antibody-drug Conjugate Sales Market Share by Application (2015-2020)
    5.2 Global Antibody-drug Conjugate Revenue Market Share by Application (2015-2020)
    5.3 Global Antibody-drug Conjugate Price by Application (2015-2020)

6 Company Profiles and Key Figures in Antibody-drug Conjugate Business
    6.1 Agensys
        6.1.1 Corporation Information
        6.1.2 Agensys Description, Business Overview and Total Revenue
        6.1.3 Agensys Antibody-drug Conjugate Sales, Revenue and Gross Margin (2015-2020)
        6.1.4 Agensys Products Offered
        6.1.5 Agensys Recent Development
    6.2 Concortis Biotherapeutics
        6.2.1 Concortis Biotherapeutics Antibody-drug Conjugate Production Sites and Area Served
        6.2.2 Concortis Biotherapeutics Description, Business Overview and Total Revenue
        6.2.3 Concortis Biotherapeutics Antibody-drug Conjugate Sales, Revenue and Gross Margin (2015-2020)
        6.2.4 Concortis Biotherapeutics Products Offered
        6.2.5 Concortis Biotherapeutics Recent Development
    6.3 Sanofi
        6.3.1 Sanofi Antibody-drug Conjugate Production Sites and Area Served
        6.3.2 Sanofi Description, Business Overview and Total Revenue
        6.3.3 Sanofi Antibody-drug Conjugate Sales, Revenue and Gross Margin (2015-2020)
        6.3.4 Sanofi Products Offered
        6.3.5 Sanofi Recent Development
    6.4 Celldex Therapeutics
        6.4.1 Celldex Therapeutics Antibody-drug Conjugate Production Sites and Area Served
        6.4.2 Celldex Therapeutics Description, Business Overview and Total Revenue
        6.4.3 Celldex Therapeutics Antibody-drug Conjugate Sales, Revenue and Gross Margin (2015-2020)
        6.4.4 Celldex Therapeutics Products Offered
        6.4.5 Celldex Therapeutics Recent Development
    6.5 Synthon Holding BV
        6.5.1 Synthon Holding BV Antibody-drug Conjugate Production Sites and Area Served
        6.5.2 Synthon Holding BV Description, Business Overview and Total Revenue
        6.5.3 Synthon Holding BV Antibody-drug Conjugate Sales, Revenue and Gross Margin (2015-2020)
        6.5.4 Synthon Holding BV Products Offered
        6.5.5 Synthon Holding BV Recent Development

7 Antibody-drug Conjugate Manufacturing Cost Analysis
    7.1 Antibody-drug Conjugate Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Raw Materials Price Trend
       7.1.3 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Antibody-drug Conjugate
    7.4 Antibody-drug Conjugate Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Antibody-drug Conjugate Distributors List
    8.3 Antibody-drug Conjugate Customers

9 Market Dynamics
    9.1 Market Trends
    9.2 Opportunities and Drivers
    9.3 Challenges
    9.4 Porter's Five Forces Analysis

10 Global Market Forecast
    10.1 Global Antibody-drug Conjugate Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Antibody-drug Conjugate by Type (2021-2026)
        10.1.2 Global Forecasted Revenue of Antibody-drug Conjugate by Type (2021-2026)
    10.2 Antibody-drug Conjugate Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Antibody-drug Conjugate by Application (2021-2026)
        10.2.2 Global Forecasted Revenue of Antibody-drug Conjugate by Application (2021-2026)
    10.3 Antibody-drug Conjugate Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Antibody-drug Conjugate by Region (2021-2026)
        10.3.2 Global Forecasted Revenue of Antibody-drug Conjugate by Region (2021-2026)
    10.4 North America Antibody-drug Conjugate Estimates and Projections (2021-2026)
    10.5 Europe Antibody-drug Conjugate Estimates and Projections (2021-2026)
    10.6 Asia Pacific Antibody-drug Conjugate Estimates and Projections (2021-2026)
    10.7 Latin America Antibody-drug Conjugate Estimates and Projections (2021-2026)
    10.8 Middle East and Africa Antibody-drug Conjugate Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Antibody-drug Conjugate Sales (K Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global Antibody-drug Conjugate Sales (K Units) Comparison by Application: 2020 VS 2026 Table 3. Global Antibody-drug Conjugate Market Size by Type (K Units) (US$ Million) (2020 VS 2026) Table 4. Global Key Antibody-drug Conjugate Manufacturers Covered in This Study Table 5. Global Antibody-drug Conjugate Sales (K Units) by Manufacturers (2015-2020) Table 6. Global Antibody-drug Conjugate Sales Share by Manufacturers (2015-2020) Table 7. Global Antibody-drug Conjugate Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Antibody-drug Conjugate Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Antibody-drug Conjugate Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers Antibody-drug Conjugate Sales Sites and Area Served Table 11. Manufacturers Antibody-drug Conjugate Product Types Table 12. Global Antibody-drug Conjugate Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Antibody-drug Conjugate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody-drug Conjugate as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Antibody-drug Conjugate Players Table 16. Global Antibody-drug Conjugate Sales (K Units) by Region (2015-2020) Table 17. Global Antibody-drug Conjugate Sales Market Share by Region (2015-2020) Table 18. Global Antibody-drug Conjugate Revenue (Million US$) by Region (2015-2020) Table 19. Global Antibody-drug Conjugate Revenue Market Share by Region (2015-2020) Table 20. North America Antibody-drug Conjugate Sales by Country (2015-2020) (K Units) Table 21. North America Antibody-drug Conjugate Sales Market Share by Country (2015-2020) Table 22. North America Antibody-drug Conjugate Revenue by Country (2015-2020) (US$ Million) Table 23. North America Antibody-drug Conjugate Revenue Market Share by Country (2015-2020) Table 24. Europe Antibody-drug Conjugate Sales by Country (2015-2020) (K Units) Table 25. Europe Antibody-drug Conjugate Sales Market Share by Country (2015-2020) Table 26. Europe Antibody-drug Conjugate Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Antibody-drug Conjugate Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Antibody-drug Conjugate Sales by Region (2015-2020) (K Units) Table 29. Asia Pacific Antibody-drug Conjugate Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Antibody-drug Conjugate Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Antibody-drug Conjugate Revenue Market Share by Region (2015-2020) Table 32. Latin America Antibody-drug Conjugate Sales by Country (2015-2020) (K Units) Table 33. Latin America Antibody-drug Conjugate Sales Market Share by Country (2015-2020) Table 34. Latin America Antibody-drug Conjugate Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Antibody-drug Conjugate Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Antibody-drug Conjugate Sales by Country (2015-2020) (K Units) Table 37. Middle East and Africa Antibody-drug Conjugate Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Antibody-drug Conjugate Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Antibody-drug Conjugate Revenue Market Share by Country (2015-2020) Table 40. Global Antibody-drug Conjugate Sales (K Units) by Type (2015-2020) Table 41. Global Antibody-drug Conjugate Sales Share by Type (2015-2020) Table 42. Global Antibody-drug Conjugate Revenue (Million US$) by Type (2015-2020) Table 43. Global Antibody-drug Conjugate Revenue Share by Type (2015-2020) Table 44. Global Antibody-drug Conjugate Price (USD/Unit) by Type (2015-2020) Table 45. Global Antibody-drug Conjugate Sales (K Units) by Application (2015-2020) Table 46. Global Antibody-drug Conjugate Sales Market Share by Application (2015-2020) Table 47. Global Antibody-drug Conjugate Sales Growth Rate by Application (2015-2020) Table 48. Agensys Antibody-drug Conjugate Corporation Information Table 49. Agensys Description and Business Overview Table 50. Agensys Antibody-drug Conjugate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 51. Agensys Main Product Table 52. Agensys Recent Development Table 53. Concortis Biotherapeutics Antibody-drug Conjugate Corporation Information Table 54. Concortis Biotherapeutics Corporation Information Table 55. Concortis Biotherapeutics Antibody-drug Conjugate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 56. Concortis Biotherapeutics Main Product Table 57. Concortis Biotherapeutics Recent Development Table 58. Sanofi Antibody-drug Conjugate Corporation Information Table 59. Sanofi Corporation Information Table 60. Sanofi Antibody-drug Conjugate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 61. Sanofi Main Product Table 62. Sanofi Recent Development Table 63. Celldex Therapeutics Antibody-drug Conjugate Corporation Information Table 64. Celldex Therapeutics Corporation Information Table 65. Celldex Therapeutics Antibody-drug Conjugate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 66. Celldex Therapeutics Main Product Table 67. Celldex Therapeutics Recent Development Table 68. Synthon Holding BV Antibody-drug Conjugate Corporation Information Table 69. Synthon Holding BV Corporation Information Table 70. Synthon Holding BV Antibody-drug Conjugate Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 71. Synthon Holding BV Main Product Table 72. Synthon Holding BV Recent Development Table 73. Sales Base and Market Concentration Rate of Raw Material Table 74. Key Suppliers of Raw Materials Table 75. Antibody-drug Conjugate Distributors List Table 76. Antibody-drug Conjugate Customers List Table 77. Market Key Trends Table 78. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 79. Key Challenges Table 80. Global Antibody-drug Conjugate Sales (K Units) Forecast by Type (2021-2026) Table 81. Global Antibody-drug Conjugate Sales Market Share Forecast by Type (2021-2026) Table 82. Global Antibody-drug Conjugate Revenue (Million US$) Forecast by Type (2021-2026) Table 83. Global Antibody-drug Conjugate Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 84. Global Antibody-drug Conjugate Sales (K Units) Forecast by Application (2021-2026) Table 85. Global Antibody-drug Conjugate Revenue (Million US$) Forecast by Application (2021-2026) Table 86. Global Antibody-drug Conjugate Sales (K Units) Forecast by Region (2021-2026) Table 87. Global Antibody-drug Conjugate Sales Market Share Forecast by Region (2021-2026) Table 88. Global Antibody-drug Conjugate Revenue Forecast by Region (2021-2026) (US$ Million) Table 89. Global Antibody-drug Conjugate Revenue Market Share Forecast by Region (2021-2026) Table 90. Research Programs/Design for This Report Table 91. Key Data Information from Secondary Sources Table 92. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Antibody-drug Conjugate Figure 2. Global Antibody-drug Conjugate Sales Market Share by Type: 2020 VS 2026 Figure 3. Adcetris Product Picture Figure 4. Kadcyla Product Picture Figure 5. Global Antibody-drug Conjugate Consumption Market Share by Application: 2020 VS 2026 Figure 6. Breast Cancer Figure 7. Lymphoma Figure 8. Global Antibody-drug Conjugate Market Size 2015-2026 (US$ Million) Figure 9. Global Antibody-drug Conjugate Sales Capacity (K Units) (2015-2026) Figure 10. Global Antibody-drug Conjugate Market Size Market Share by Region: 2020 Versus 2026 Figure 11. Antibody-drug Conjugate Sales Share by Manufacturers in 2020 Figure 12. Global Antibody-drug Conjugate Revenue Share by Manufacturers in 2019 Figure 13. The Global 5 and 10 Largest Players: Market Share by Antibody-drug Conjugate Revenue in 2019 Figure 14. Antibody-drug Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 15. Global Antibody-drug Conjugate Sales Market Share by Region (2015-2020) Figure 16. Global Antibody-drug Conjugate Sales Market Share by Region in 2019 Figure 17. Global Antibody-drug Conjugate Revenue Market Share by Region (2015-2020) Figure 18. Global Antibody-drug Conjugate Revenue Market Share by Region in 2019 Figure 19. North America Antibody-drug Conjugate Sales Market Share by Country in 2019 Figure 20. North America Antibody-drug Conjugate Revenue Market Share by Country in 2019 Figure 21. U.S. Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units) Figure 22. U.S. Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million) Figure 23. Canada Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units) Figure 24. Canada Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Europe Antibody-drug Conjugate Sales Market Share by Country in 2019 Figure 26. Europe Antibody-drug Conjugate Revenue Market Share by Country in 2019 Figure 27. Germany Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units) Figure 28. Germany Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million) Figure 29. France Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units) Figure 30. France Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. U.K. Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units) Figure 32. U.K. Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. Italy Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units) Figure 34. Italy Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Russia Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units) Figure 36. Russia Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Asia Pacific Antibody-drug Conjugate Sales Market Share by Region in 2019 Figure 38. Asia Pacific Antibody-drug Conjugate Revenue Market Share by Region in 2019 Figure 39. China Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units) Figure 40. China Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Japan Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units) Figure 42. Japan Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. South Korea Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units) Figure 44. South Korea Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. India Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units) Figure 46. India Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. Australia Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units) Figure 48. Australia Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Taiwan Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units) Figure 50. Taiwan Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Indonesia Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units) Figure 52. Indonesia Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Thailand Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units) Figure 54. Thailand Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Malaysia Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units) Figure 56. Malaysia Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Philippines Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units) Figure 58. Philippines Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Vietnam Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units) Figure 60. Vietnam Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Latin America Antibody-drug Conjugate Sales Market Share by Country in 2019 Figure 62. Latin America Antibody-drug Conjugate Revenue Market Share by Country in 2019 Figure 63. Mexico Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units) Figure 64. Mexico Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Brazil Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units) Figure 66. Brazil Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Argentina Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units) Figure 68. Argentina Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Middle East and Africa Antibody-drug Conjugate Sales Market Share by Country in 2019 Figure 70. Middle East and Africa Antibody-drug Conjugate Revenue Market Share by Country in 2019 Figure 71. Turkey Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units) Figure 72. Turkey Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Saudi Arabia Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units) Figure 74. Saudi Arabia Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. U.A.E Antibody-drug Conjugate Sales Growth Rate (2015-2020) (K Units) Figure 76. U.A.E Antibody-drug Conjugate Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Sales Market Share of Antibody-drug Conjugate by Type (2015-2020) Figure 78. Sales Market Share of Antibody-drug Conjugate by Type in 2019 Figure 79. Revenue Share of Antibody-drug Conjugate by Type (2015-2020) Figure 80. Revenue Market Share of Antibody-drug Conjugate by Type in 2019 Figure 81. Global Antibody-drug Conjugate Sales Growth by Type (2015-2020) (K Units) Figure 82. Global Antibody-drug Conjugate Sales Market Share by Application (2015-2020) Figure 83. Global Antibody-drug Conjugate Sales Market Share by Application in 2019 Figure 84. Global Revenue Share of Antibody-drug Conjugate by Application (2015-2020) Figure 85. Global Revenue Share of Antibody-drug Conjugate by Application in 2020 Figure 86. Agensys Total Revenue (US$ Million): 2019 Compared with 2018 Figure 87. Concortis Biotherapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Celldex Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Synthon Holding BV Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Price Trend of Key Raw Materials Figure 92. Manufacturing Cost Structure of Antibody-drug Conjugate Figure 93. Manufacturing Process Analysis of Antibody-drug Conjugate Figure 94. Antibody-drug Conjugate Industrial Chain Analysis Figure 95. Channels of Distribution Figure 96. Distributors Profiles Figure 97. Porter's Five Forces Analysis Figure 98. North America Antibody-drug Conjugate Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 99. North America Antibody-drug Conjugate Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 100. Europe Antibody-drug Conjugate Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 101. Europe Antibody-drug Conjugate Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 102. Latin America Antibody-drug Conjugate Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 103. Latin America Antibody-drug Conjugate Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 104. Middle East and Africa Antibody-drug Conjugate Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 105. Middle East and Africa Antibody-drug Conjugate Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 106. Asia Pacific Antibody-drug Conjugate Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 107. Asia Pacific Antibody-drug Conjugate Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 108. Bottom-up and Top-down Approaches for This Report Figure 109. Data Triangulation Figure 110. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Gelatin Capsule Market Research Report Analysis and Forecasts to 2025

Going by the estimates of reliable sources, the global gelatin capsule market is presumed to expand with 6.6% CAGR during 2020-2025, hence crossing a market valuation of USD 5012 million by the year 2025. Surging occurrence of lifestyle disorders lik...

Polymers for Implantable Medical Devices Market Size, Share | Industry Analysis Report, 2025

As per credible estimates, the global polymers for implantable medical devices market was worth USD 992.9 million in the year 2019 and is expected to grow with a CAGR of 3.6% during 2020-2025, hence reaching USD 1143.3 million by the end of study per...

Other Reports by QY Research

Global Passive Sonar System Market Size, Status and Forecast 2020-2026

This report focuses on the global Passive Sonar System status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Passive Sonar System development in North America, Europe, China, Japan, Southeast...

Global Fowl Feeding Systems Market Size, Status and Forecast 2020-2026

This report focuses on the global Fowl Feeding Systems status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Fowl Feeding Systems development in North America, Europe, China, Japan, Southeast...

Global Neuronavigation Systems Market Size, Status and Forecast 2020-2026

This report focuses on the global Neuronavigation Systems status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Neuronavigation Systems development in North America, Europe, China, Japan, Sou...

Global Nitrogen Purge Systems Market Size, Status and Forecast 2020-2026

This report focuses on the global Nitrogen Purge Systems status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nitrogen Purge Systems development in North America, Europe, China, Japan, South...

Global Protein Purification System Market Size, Status and Forecast 2020-2026

This report focuses on the global Protein Purification System status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Protein Purification System development in North America, Europe, China, Ja...

Publisher: QY Research